» Authors » Fereshteh Alsahebfosoul

Fereshteh Alsahebfosoul

Explore the profile of Fereshteh Alsahebfosoul including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 212
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sadatmadani S, Siadat A, Iraji F, Alsahebfosoul F
Adv Biomed Res . 2023 Mar; 12:16. PMID: 36926437
Background: Psoriasis (PSO) is a common chronic autoimmune skin disease with a significant psycho-socio-economic burden. Some antidepressants (ADs) such as fluoxetine and bupropion can induce or exacerbate PSO. This study...
2.
Ahmadi L, Eskandari N, Ghanadian M, Rahmati M, Kasiri N, Etamadifar M, et al.
Cell J . 2023 Feb; 25(2):110-117. PMID: 36840457
Objective: The function of Th17 cells in the neuroinflammatory process in multiple sclerosis (MS) has been previously clarified. It has been suggested that Quercetin can influence MS due to a...
3.
Alipour R, Sereshki N, Rafiee M, Mofid M, Alsahebfosoul F, Pourazar A
Immunobiology . 2022 Mar; 227(3):152193. PMID: 35240404
Uncontrolled inflammation is the underlining mechanism of many human diseases and the increasing prevalence of such diseases mandate to develop new anti-inflammatory treatments. Utilizing the anti-inflammatory properties as well as...
4.
Shajarian M, Alsahebfosoul F, Etemadifar M
Neuroimmunomodulation . 2021 Jun; 28(3):150-157. PMID: 34182566
Background: In recent investigations addressing neurodegenerative diseases, especially multiple sclerosis (MS), the roles of brain-derived neurotrophic factor (BDNF) and interleukin-6 (IL-6) have been examined. Methods: Forty-five relapsing-remitting MS (RRMS) patients,...
5.
Jafarinia M, Alsahebfosoul F, Salehi H, Eskandari N, Azimzadeh M, Mahmoodi M, et al.
J Cell Physiol . 2020 Apr; 235(11):8779-8790. PMID: 32329062
Since in cell therapy, there are always concerns about immune rejection, genetic disability, and malignancies, special attention has been paid to extracellular vesicles (EVs) which are secreted by mesenchymal stem...
6.
Rahmati M, Ghannadian S, Kasiri N, Ahmadi L, Motedayyen H, Shaygannejad V, et al.
Immunol Invest . 2020 Feb; 50(2-3):216-229. PMID: 32100582
The presence of Th17 cells in CNS lesion of MS patients due to their inflammatory cytokines secretion is in line with the deterioration of the disease. Currently, the use of...
7.
Jafarinia M, Alsahebfosoul F, Salehi H, Eskandari N, Ganjalikhani-Hakemi M
Immunol Invest . 2020 Feb; 49(7):758-780. PMID: 32009478
In recent years, mesenchymal stem/stromal cells (MSCs) have widely been considered as therapeutic tools in basic researches and clinical trials. Accumulating evidence supports the idea that MSCs perform their therapeutic...
8.
Jafarinia M, Amoon M, Javid A, Vakili S, Sadeghi E, Azadi D, et al.
Int J Immunogenet . 2019 Dec; 47(2):175-179. PMID: 31833227
Multiple sclerosis (MS) is referred to as an organ-specific T-cell-mediated autoimmune disease of the central nervous system (CNS). Different genetic and environmental factors increase the risk of developing MS. In...
9.
Jafarinia M, Sadeghi E, Alsahebfosoul F, Etemadifar M, Jahanbani-Ardakani H
Int J Neurosci . 2019 Dec; 130(5):493-498. PMID: 31795798
Multiple sclerosis (MS) is known as a neuroinflammatory disease of the central nervous system (CNS). The neuroinflammation may induce pro-inflammatory cytokines such as Osteopontin (OPN). OPN plays an important role...
10.
Jahanbani-Ardakani H, Alsahebfosoul F, Etemadifar M, Abtahi S
Ann Indian Acad Neurol . 2019 Nov; 22(4):474-476. PMID: 31736573
Background: Multiple sclerosis (MS) is a chronic demyelinating disorder of central nervous system. Although the definite pathogenesis of MS has not been understood, crucial role of environmental and genetic risk...